http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10179129-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_662aac4d5e83fce95e00fd5d77851777
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-12
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-12
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-404
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
filingDate 2018-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33dbe0ee9cf083fbfb88f10f058147d3
publicationDate 2019-01-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-10179129-B2
titleOfInvention Prophylactic leukotriene inhibitor and implant displacement therapy for prevention and treatment of capsular contracture in silicone breast augmentation
abstract A method of treating or preventing capsular contracture in a patient resulting from surgical insertion of a silicone breast implant in a surgically created implant pocket. The method includes administering to the patient a therapeutically effective amount of a leukotriene receptor antagonist prior to the formation of a capsular contracture in the patient. The method further includes administering a therapeutically effective amount of displacement of the breast implant within the surgically created implant pocket, the therapeutically effective amount of displacement of the breast implant being administered post-surgically but prior to the formation of a capsular contracture in the patient.
priorityDate 2017-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003162828-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013079348-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23675322
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396221
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444899
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5717
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57206935
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394779
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395183
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395403
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5281040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400334
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395182
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425910
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400333
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663996
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57134040
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406377
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5312542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446598
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6604080
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395375
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396470
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406378

Total number of triples: 44.